114 related articles for article (PubMed ID: 18508245)
41. Neurological soft signs and brain morphology in first-episode schizophrenia.
Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
[TBL] [Abstract][Full Text] [Related]
42. No change in neuron numbers in the dentate nucleus of patients with schizophrenia estimated with a new stereological method--the smooth fractionator.
Andersen BB; Fabricius K; Gundersen HJ; Jelsing J; Stark AK
J Anat; 2004 Oct; 205(4):313-21. PubMed ID: 15447690
[TBL] [Abstract][Full Text] [Related]
43. The relationship between prefrontal brain volume and characteristics of memory strategy in schizophrenia spectrum disorders.
Matsui M; Suzuki M; Zhou SY; Takahashi T; Kawasaki Y; Yuuki H; Kato K; Kurachi M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1854-62. PubMed ID: 18796324
[TBL] [Abstract][Full Text] [Related]
44. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.
Cotter D; Mackay D; Chana G; Beasley C; Landau S; Everall IP
Cereb Cortex; 2002 Apr; 12(4):386-94. PubMed ID: 11884354
[TBL] [Abstract][Full Text] [Related]
45. Quantitative analysis of the columnar arrangement of neurons in the human cingulate cortex.
Schlaug G; Schleicher A; Zilles K
J Comp Neurol; 1995 Jan; 351(3):441-52. PubMed ID: 7706552
[TBL] [Abstract][Full Text] [Related]
46. Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia.
Takizawa R; Hashimoto K; Tochigi M; Kawakubo Y; Marumo K; Sasaki T; Fukuda M; Kasai K
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):491-8. PubMed ID: 19439245
[TBL] [Abstract][Full Text] [Related]
47. Dysfunctional modulation of emotional interference in the medial prefrontal cortex in patients with schizophrenia.
Park IH; Park HJ; Chun JW; Kim EY; Kim JJ
Neurosci Lett; 2008 Aug; 440(2):119-24. PubMed ID: 18562102
[TBL] [Abstract][Full Text] [Related]
48. Depression-related variation in brain morphology over 3 years: effects of stress?
Frodl TS; Koutsouleris N; Bottlender R; Born C; Jäger M; Scupin I; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2008 Oct; 65(10):1156-65. PubMed ID: 18838632
[TBL] [Abstract][Full Text] [Related]
49. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria.
Rajkowska G; Goldman-Rakic PS
Cereb Cortex; 1995; 5(4):307-22. PubMed ID: 7580124
[TBL] [Abstract][Full Text] [Related]
50. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
51. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease.
Rajkowska G; Selemon LD; Goldman-Rakic PS
Arch Gen Psychiatry; 1998 Mar; 55(3):215-24. PubMed ID: 9510215
[TBL] [Abstract][Full Text] [Related]
52. Working memory in schizophrenia: an EEG study using power spectrum and coherence analysis to estimate cortical activation and network behavior.
Pachou E; Vourkas M; Simos P; Smit D; Stam CJ; Tsirka V; Micheloyannis S
Brain Topogr; 2008 Dec; 21(2):128-37. PubMed ID: 18726681
[TBL] [Abstract][Full Text] [Related]
53. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
[TBL] [Abstract][Full Text] [Related]
54. Brain volume and dysexecutive behavior in schizophrenia.
Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
[TBL] [Abstract][Full Text] [Related]
55. Reduced oligodendrocyte density in layer 5 of the prefrontal cortex in schizophrenia.
Kolomeets NS; Uranova NA
Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):379-386. PubMed ID: 29572659
[TBL] [Abstract][Full Text] [Related]
56. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
Thompson M; Weickert CS; Wyatt E; Webster MJ
J Psychiatr Res; 2009 Jul; 43(11):970-7. PubMed ID: 19321177
[TBL] [Abstract][Full Text] [Related]
57. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.
Benes FM; Davidson J; Bird ED
Arch Gen Psychiatry; 1986 Jan; 43(1):31-5. PubMed ID: 3942472
[TBL] [Abstract][Full Text] [Related]
58. fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia.
Whalley HC; Gountouna VE; Hall J; McIntosh AM; Simonotto E; Job DE; Owens DG; Johnstone EC; Lawrie SM
Psychol Med; 2009 Jul; 39(7):1189-99. PubMed ID: 19105855
[TBL] [Abstract][Full Text] [Related]
59. Retrosplenial cortex connectivity in schizophrenia.
Bluhm RL; Miller J; Lanius RA; Osuch EA; Boksman K; Neufeld RW; Théberge J; Schaefer B; Williamson PC
Psychiatry Res; 2009 Oct; 174(1):17-23. PubMed ID: 19783410
[TBL] [Abstract][Full Text] [Related]
60. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.
Uranova NA; Vostrikov VM; Orlovskaya DD; Rachmanova VI
Schizophr Res; 2004 Apr; 67(2-3):269-75. PubMed ID: 14984887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
